Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

TetraGraph in Rocuronium Infusions

NCT: NCT06472284 · COMPLETED

NCT IDNCT06472284
StatusCOMPLETED
Start Date2024-09-12
Completion2025-04-24

Brief Summary

This is a prospective, non-blinded study to evaluate rocuronium infusion requirements using the TetraGraph Neuromuscular Transmission Monitor during surgical procedures in patients less than 18 yrs. of age.

Frequently Asked Questions

What is TetraGraph in Rocuronium Infusions?

TetraGraph in Rocuronium Infusions is a clinical trial registered under NCT06472284. Current status: COMPLETED.

What is the status of NCT06472284?

The current status of NCT06472284 (TetraGraph in Rocuronium Infusions) is: COMPLETED.

When did TetraGraph in Rocuronium Infusions start?

TetraGraph in Rocuronium Infusions started on 2024-09-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑